Ninety One Sa (Pty) LTD Pfizer Inc Transaction History

Ninety One Sa (Pty) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $47,545 - $67,932	-1,759 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $11,130 - $12,497	-301 Reduced 14.61%	1,759 $76,000
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $637 - $700	-17 Reduced 0.82%	2,060 $87,000
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $2.33 Million - $2.65 Million	-60,495 Reduced 96.68%	2,077 $90,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $11.6 Million - $14.1 Million	-337,700 Reduced 84.37%	62,572 $2.76 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $2 Million - $2.13 Million	60,495 Added 17.8%	400,272 $14.6 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $10.5 Million - $11.6 Million	339,777	339,777 $12.1 Million

3,244

3.72B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ninety One Sa (Pty) LTD, based on Form 13F filings with the SEC.

Stay updated on Ninety One Sa (Pty) LTD with notifications on news.